STEMI patients treated with second-generation drug-eluting stents experience similar or better one-year outcomes as those treated with bare-metal stents, according to a study published in Circulation: Cardiovascular Interventions. "In acute MI, we should not be hesitant to use DES over BMS," said Dr. Samir R. Kapadia. However, Dr. Gregg W. Stone noted the research used largely indirect data, saying clearer evidence will come with findings from a randomized trial next year.

Full Story:

Related Summaries